Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi QingLan Bio-Technology is a synthetic biology enterprise based in Xi'an, China, specializing in the green manufacturing of high-value bioactive substances. The company utilizes advanced microbial cell factories and enzymatic catalysis to produce human milk oligosaccharides (HMOs), functional peptides, and pharmaceutical intermediates. By leveraging its proprietary technology platform, QingLan Bio aims to replace traditional, high-pollution chemical synthesis with sustainable and cost-effective bio-manufacturing processes. Its products primarily serve the global infant formula, dietary supplement, and personal care industries, with a focus on promoting gut health and skin repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi QingLan Bio-Technology.